Taro RX product details
Product Information
-
DIN:02303728
-
Active Ingredients :ciprofloxacin hydrochloride
-
Innovator Name:Cipro®
-
Category:Antibiotic
-
Dosage form:Tablet
-
Strength:250mg
- Package size:
100 Bottle - UPC Code:
876515008677 -
Non-medicinal ingredients :colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, starch (corn) and talc. The coating of the tablet also contains hypromellose, polyethylene glycol, and titanium dioxide
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02303736
-
Active Ingredients :ciprofloxacin hydrochloride
-
Innovator Name:Cipro®
-
Category:Antibiotic
-
Dosage form:Tablet
-
Strength:500mg
- Package size:
100 Bottle - UPC Code:
876515008684 -
Non-medicinal ingredients :colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, starch (corn) and talc. The coating of the tablet also contains hypromellose, polyethylene glycol, and titanium dioxide
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02303744
-
Active Ingredients :ciprofloxacin hydrochloride
-
Innovator Name:Cipro®
-
Category:Antibiotic
-
Dosage form:Tablet
-
Strength:750mg
- Package size:
100 Bottle - UPC Code:
876515008691 -
Non-medicinal ingredients :colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, starch (corn) and talc. The coating of the tablet also contains hypromellose, polyethylene glycol, and titanium dioxide
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here